Equity

UnitedHealth Group·Balance Sheet Statement·21 metrics

Breakdown

Metric	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Total liabilities and stockholders' equity	$286.1B	$299.3B	$298.3B	$309.8B	$308.6B	$315.3B	$309.6B	$312.6B
Total stockholders' equity	$94.7B	$99.9B	$98.3B	$100.8B	$100.5B	$101.6B	$100.1B	$103.9B
Retained earnings	$92.4B	$96.5B	$96B	$97.9B	$97.3B	$97.6B	$95.6B	$99.9B
Noncontrolling interests	$5.3B	$5.3B	$5.6B	$5.8B	$5.7B	$5.8B	$6B	$6B
Common stock	3B	3B	9M	3B	3B	3B	3B	3B
Accumulated other comprehensive income (loss)	-$3.4B	-$2.5B	-$3.4B	-$2.9B	-$2.5B	-$2.2B	-$2.1B	-$2.6B
Unrealized Losses on Investments (Before Tax)	$3B	$2B	$3B	$2.5B	$2.2B	$1.8B	$1.6B	$1.9B
Redeemable noncontrolling interests	$4.6B	$4.6B	$4.3B	$4.4B	$4.3B	$4.2B	$1.6B	$1.4B
Common Stock Shares Issued	921M	923M	915M	910M	905M	906M	906M	908M
Additional paid-in capital	$373M	$461M	$0	—	—	$394M	$559M	$556M
Unrealized Gains on Investments	$21M	$137M	$62M	$78M	$131M	$214M	$229M	$116M
Convertible Preferred Stock Authorized Shares	10M	10M	10M	10M	10M	10M	10M	10M
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$9M	$9M	$9M	$9M	$9M	$9M	$9M	$9M
Cumulative Gross Losses and Impairments	$7M	$4M	$4M	$4M	$4M	$3M	$3M	$4M
Cumulative Gross Unrealized Gains	$0	$1M	$0	$1M	$1M	$1M	$2M	$1M
Common Stock Par Value Per Share	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01	$0.01
Preferred Stock Par Value Per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Convertible Preferred Stock Issued Shares	0	0	0	0	0	0	0	0
Convertible Preferred Stock Outstanding Shares	0	0	0	0	0	0	0	0
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0	$0	$0	$0	$0	$0	$0	$0
Preferred stock	$0	$0	$0	$0	$0	$0	$0	$0